» Articles » PMID: 3361663

Effects of Botulinum A Toxin on Detrusor-sphincter Dyssynergia in Spinal Cord Injury Patients

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1988 May 1
PMID 3361663
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated the ability of low doses of botulinum A toxin, an inhibitor of acetylcholine release at the neuromuscular junction, to denervate and relax the spastic rhabdosphincter in 11 men with spinal cord injury and detrusor-sphincter dyssynergia. Toxin concentration, injection volume, percutaneous versus cystoscopic injection of the sphincter and number of injections were evaluated in 3 treatment protocols. All 10 patients evaluated by electromyography after injection showed signs of sphincter denervation. Bulbosphincteric reflexes in the 10 patients evaluated after injection were more difficult to obtain, and they showed a decreased amplitude and normal latency. The urethral pressure profile in the 7 patients in whom it was measured before and after treatment decreased an average of 27 cm. water after toxin injections. Post-void residual urine volume decreased by an average of 146 cc after the toxin injections in 8 patients. In the 8 patients for whom it could be determined toxin effects lasted an average of 50 days. The toxin also decreased autonomic dysreflexia in 5 patients.

Citing Articles

[Functional disorders of the lower urinary tract: Parkinson's disease].

Knupfer S Urologie. 2025; 64(2):120-127.

PMID: 39900843 DOI: 10.1007/s00120-024-02508-y.


Long-term Outcomes of Periurethral Sphincter Botulinum Toxin in Female Chronic Urinary Retention.

Wright S, Ananthavarathan P, Simeoni S, Malladi P, Pakzad M, Panicker J Int Neurourol J. 2024; 28(3):207-214.

PMID: 39363411 PMC: 11450239. DOI: 10.5213/inj.2448176.088.


OnabotulinumtoxinA is now an important tool for managing pediatric neurogenic lower urinary tract dysfunction.

Frainey B, Clayton D Front Pediatr. 2024; 12:1407009.

PMID: 38887561 PMC: 11180881. DOI: 10.3389/fped.2024.1407009.


The Efficacy and Safety of Intrasphincteric Botulinum Toxin-A Injections in Patients with Non-Spinal Cord Injury-Related Detrusor Sphincter Dyssynergia: A Retrospective Study.

Rothlin K, Anding R, Seifert H, Hund-Georgiadis M, Mohr S, Walter M Biomedicines. 2023; 11(11).

PMID: 38002018 PMC: 10669099. DOI: 10.3390/biomedicines11113016.


Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact.

Nitti V, Haag-Molkenteller C, Kennelly M, Chancellor M, Jenkins B, Schurch B Medicine (Baltimore). 2023; 102(S1):e32377.

PMID: 37499088 PMC: 10374192. DOI: 10.1097/MD.0000000000032377.